449 related articles for article (PubMed ID: 11100995)
1. Non-steroidal anti-inflammatory drug toxicity in the upper gastrointestinal tract.
Sung J; Russell RI; Nyeomans ; Chan FK; Chen S; Fock K; Goh KL; Kullavanijaya P; Kimura K; Lau C; Louw J; Sollano J; Triadiafalopulos G; Xiao S; Brooks P
J Gastroenterol Hepatol; 2000 Oct; 15 Suppl():G58-68. PubMed ID: 11100995
[TBL] [Abstract][Full Text] [Related]
2. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
;
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
[TBL] [Abstract][Full Text] [Related]
3. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Chan FK; Graham DY
Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
[TBL] [Abstract][Full Text] [Related]
4. [Guidelines of prevention and treatment for NSAID-related peptic ulcers].
Lee JH; Lee YC; Jeon SW; Kim JW; Lee SW; ;
Korean J Gastroenterol; 2009 Nov; 54(5):309-17. PubMed ID: 19934612
[TBL] [Abstract][Full Text] [Related]
5. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
6. Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.
Ji KY; Hu FL
World J Gastroenterol; 2006 Jun; 12(24):3789-92. PubMed ID: 16804960
[TBL] [Abstract][Full Text] [Related]
7. Non-steroidal anti-inflammatory drug gastropathy: causes and treatment.
Hawkey CJ
Scand J Gastroenterol Suppl; 1996; 220():124-7. PubMed ID: 8898449
[TBL] [Abstract][Full Text] [Related]
8. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
Graham DY
Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
[TBL] [Abstract][Full Text] [Related]
10. Reducing NSAID-induced gastrointestinal complications.
Drug Ther Bull; 2011 Feb; 49(2):18-21; quiz i-ii. PubMed ID: 21304164
[TBL] [Abstract][Full Text] [Related]
11. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.
Iwamoto J; Saito Y; Honda A; Matsuzaki Y
World J Gastroenterol; 2013 Mar; 19(11):1673-82. PubMed ID: 23555156
[TBL] [Abstract][Full Text] [Related]
13. Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing.
Hunt RH; Bazzoli F
Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():9-16. PubMed ID: 14725573
[TBL] [Abstract][Full Text] [Related]
14. Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors.
Lazzaroni M; Porro GB
Drugs; 2009; 69(1):51-69. PubMed ID: 19192936
[TBL] [Abstract][Full Text] [Related]
15. COX-2 inhibitors vs. NSAIDs in gastrointestinal damage and prevention.
Ballinger A; Smith G
Expert Opin Pharmacother; 2001 Jan; 2(1):31-40. PubMed ID: 11336566
[TBL] [Abstract][Full Text] [Related]
16. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; KwiecieĊ S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori infection and the use of NSAIDs.
Bazzoli F; De Luca L; Graham DY
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
[TBL] [Abstract][Full Text] [Related]
18. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
Lanas A; Ferrandez A
Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
[TBL] [Abstract][Full Text] [Related]
19. NSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient management.
Chan FK
Drug Saf; 2005; 28(4):287-300. PubMed ID: 15783239
[TBL] [Abstract][Full Text] [Related]
20. Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs.
Naesdal J; Wilson I
Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1401-6. PubMed ID: 11742186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
